{
  "trial_id": "NCT01648569",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "PTC of all tumor sizes underwent initial surgical therapy at our institution",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "2441 patients (48.4%) had PTMCs \u22641 cm in diameter",
      "label": "met",
      "evidence": "quote"
    },
    {
      "criterion": "Complete follow-up data for major clinical events were available for 2014 patients (82.5%)",
      "label": "met",
      "evidence": "quote"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with follow-up loss",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient has metastatic papillary thyroid cancer and underwent XRT, which may impact eligibility.",
  "_meta": {
    "topic_id": "11",
    "trial_id": "NCT01648569",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}